Radiation Oncology

Publications

• Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer

  (G. NoidrnA. TairnH. ZhongrnJ. ShahrnE.M. GorernA. Li.) International Journal of Radiation Oncology Biology Physics. G. Noid, A. Tai, H. Zhong, J. Shah, E.M. Gore, A. Li, Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021

• Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac

  (A. M. Schottstaedt, E. S. Paulson, J. Rubenstein, X. Chen, E. Omari, A. Li, E. M. Gore, C. J. Schultz, W. A. Hall.) International Journal of Radiation Oncology Biology Physics. A.M. Schottstaedt, E.S. Paulson, J. Rubenstein, X. Chen, E. Omari, A. Li, E.M. Gore, C.J. Schultz, W.A. Hall, Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac, International Journal of Radiation Oncology*Biology*Physics, Volume 111, Issue 3, Supplement, 2021 11/01/2021

• Evaluation of Radiation-induced Pleural Effusions after Radiotherapy to Support Development of Animal Models of Radiation Pneumonitis.

  (Aqeel M, Medhora M, Gore E, Borkenhagen J, Klawikowski S, Eastwood D, Banerjee A, Jacobs ER.) Health Phys. 2021 10 01;121(4):434-443 PMID: 34546223 PMCID: PMC8500166 SCOPUS ID: 2-s2.0-85117425583 09/22/2021

• Clinical Implementation and Initial Experience of Real-Time Motion Tracking With Jaws and Multileaf Collimator During Helical Tomotherapy Delivery.

  (Chen GP, Tai A, Puckett L, Gore E, Lim S, Keiper T, Johnstone C, Shukla M, Lawton C, Li XA.) Pract Radiat Oncol. 2021 Sep-Oct;11(5):e486-e495 PMID: 33578002 SCOPUS ID: 2-s2.0-85102461455 02/13/2021

• Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model.

  (Ibrahim EH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C.) JACC CardioOncol. 2021 Mar;3(1):113-130 PMID: 33912843 PMCID: PMC8078846 04/30/2021

• Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging.

  (Ibrahim EH, Frank L, Baruah D, Arpinar VE, Nencka AS, Koch KM, Muftuler LT, Unal O, Stojanovska J, Rubenstein JC, Brown SA, Charlson J, Gore EM, Bergom C.) Int J Biomed Imaging. 2021;2021:8851958 PMID: 34054936 PMCID: PMC8147553 SCOPUS ID: 2-s2.0-85107219799 06/01/2021

• Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model

  (Ibrahim ESH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C.) JACC: CardioOncology. March 2021;3(1):113-130 SCOPUS ID: 2-s2.0-85102143842 03/01/2021

• Optimized cardiac functional MRI of small-animal models of cancer radiation therapy.

  (Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C.) Magn Reson Imaging. 2020 11;73:130-137 PMID: 32866598 PMCID: PMC7530081 SCOPUS ID: 2-s2.0-85090239163 09/01/2020

• Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617.

  (Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J.) Clin Cancer Res. 2020 09 01;26(17):4643-4650 PMID: 32398326 PMCID: PMC7877447 SCOPUS ID: 2-s2.0-85086172648 05/14/2020

• Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) Int J Radiat Oncol Biol Phys. 2020 07 15;107(4):631-640 PMID: 32589990 PMCID: PMC7836268 SCOPUS ID: 2-s2.0-85086713288 06/27/2020

• Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

  (Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D.) International Journal of Radiation Oncology Biology Physics. 15 July 2020;107(4):631-640 SCOPUS ID: 2-s2.0-85086713288 07/15/2020

• Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial

  (B. Movsas, J. Rodgers, M. A. Elshaikh, A. A. Martinez, G. Morton, D. J. Krauss, D. Yan, D. E. Citrin, B. Hershatter, J. M. Michalski, R. J. Ellis III, V. S. Kavadi, E. M. Gore, G. S. Gustafson, C. A. Schulz, V. Velker, A. C. Olson, T. G. Karrison, H. M. Sandler, D. W. Bruner.) International Journal of Radiation Oncology Biology Physics. B. Movsas, J. Rodgers, M.A. Elshaikh, A.A. Martinez, G. Morton, D.J. Krauss, D. Yan, D.E. Citrin, B. Hershatter, J.M. Michalski, R.J. Ellis, V.S. Kavadi, E.M. Gore, G.S. Gustafson, C.A. Schulz, V. Velker, A.C. Olson, T.G. Karrison, H.M. Sandler, D.W. Bruner, Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial, International 11/01/2021